HC Wainwright Issues Pessimistic Forecast for Clearside Biomedical (NASDAQ:CLSD) Stock Price
Clearside Biomedical (NASDAQ:CLSD – Free Report) had its price target reduced by HC Wainwright from $6.00 to $5.00 in a report released on Friday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. Other research analysts also recently issued research reports about the stock. Needham & Company LLC decreased their price objective […]
Clearside Biomedical (NASDAQ:CLSD – Free Report) had its price target reduced by HC Wainwright from $6.00 to $5.00 in a report released on Friday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. Other research analysts also recently issued research reports about the stock. Needham & Company LLC decreased their price objective […]
